Canada markets closed

Primo Nutraceuticals Inc. (BUGVF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 01:53PM EDT

Primo Nutraceuticals Inc.

890 West Pender Street
Suite 440
Vancouver, BC V6C 1J9
Canada
877-517-7816
https://www.primonutraceuticals.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Richard CindricCEO & DirectorN/AN/AN/A
Mr. Amandip JagpalPresident & DirectorN/AN/A1972
Mr. Teja J. Singh CPA, CGACFO & DirectorN/AN/AN/A
Mr. Bal BhullarVice President of Legal Affairs & Corporate DevelopmentN/AN/AN/A
Mr. Andy DhaliwalVice President of Sales and DistributionN/AN/AN/A
Mr. Mark BechtelCorporate SecretaryN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Primo Nutraceuticals Inc. owns and develops commercial real estate properties for the cannabis cultivation sector in Canada. It offers built out turnkey facilities equipped with infrastructure to cannabis growers and processors. It owns hemp project in Oregon state and the greenhouse campus in Washington state. The company was formerly known as Bougainville Ventures Inc. and changed its name to Primo Nutraceuticals Inc. in October 2019. Primo Nutraceuticals Inc. was incorporated in 2014 and is based in Vancouver, Canada.

Corporate Governance

Primo Nutraceuticals Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.